531146 Stock Overview
A pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Medicamen Biotech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹431.40 |
| 52 Week High | ₹655.00 |
| 52 Week Low | ₹356.75 |
| Beta | 1.5 |
| 11 Month Change | -11.38% |
| 3 Month Change | 5.71% |
| 1 Year Change | -32.56% |
| 33 Year Change | -29.81% |
| 5 Year Change | 39.34% |
| Change since IPO | 2,970.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531146 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -4.3% | -0.2% | 0.3% |
| 1Y | -32.6% | 40.5% | 27.3% |
Return vs Industry: 531146 underperformed the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 531146 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| 531146 volatility | |
|---|---|
| 531146 Average Weekly Movement | 8.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 531146's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 531146's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 378 | Rajesh Madan | www.medicamen.com |
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarial, vitamins and supplements, other generics, and pain management.
Medicamen Biotech Limited Fundamentals Summary
| 531146 fundamental statistics | |
|---|---|
| Market cap | ₹5.49b |
| Earnings (TTM) | ₹81.05m |
| Revenue (TTM) | ₹1.80b |
67.7x
P/E Ratio3.0x
P/S RatioIs 531146 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531146 income statement (TTM) | |
|---|---|
| Revenue | ₹1.80b |
| Cost of Revenue | ₹958.22m |
| Gross Profit | ₹845.89m |
| Other Expenses | ₹764.84m |
| Earnings | ₹81.05m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.37 |
| Gross Margin | 46.89% |
| Net Profit Margin | 4.49% |
| Debt/Equity Ratio | 15.4% |
How did 531146 perform over the long term?
See historical performance and comparison